Heart failure (HF) remains a major cause of mortality, morbidity, and poor quality of life. It is
an area of active research. This article is aimed to give an update on recent advances in all …

Research about heart failure (HF) has made major progress in the last years. We give here
an update on the most recent findings. Landmark trials have established new treatments for …

The prevalence of heart failure (HF) due to cardiac remodelling after acute myocardial
infarction (AMI) does not decrease regardless of implementation of new technologies …

Despite the enhanced knowledge of the pathophysiology of heart failure (HF), it still remains
a serious syndrome with substantial morbidity, mortality, and frequent hospitalizations …

Heart failure (HF) is a complex disease in which cardiomyocyte injury leads to a cascade of
inflammatory and fibrosis pathway activation, thereby causing decrease in cardiac function …

Aims Plasma concentrations of high-sensitivity C-reactive protein (hsCRP) are often raised
in chronic heart failure (CHF) and might indicate inflammatory processes that could be a …

Adrenomedullin (AM) is a vasodilative peptide with various physiological functions,
including the maintenance of vascular tone and endothelial barrier function. AM levels are …

Numerous clinical studies have revealed the utility of circulating AM (adrenomedullin) or MR-
proAM (mid-regional proAM 45-92) as an effective prognostic and diagnostic biomarker for a …

Aims Chronic kidney dysfunction (CKD) and persistent congestion influence heart failure
prognosis, but little is known about the role of inflammation in this association. We assessed …

High-sensitivity cardiac troponin (hs-cTn) assays have the ability to detect minute troponin
concentrations and resolve minor changes in biomarker concentrations. Clinically, this …